The brain-derived neurotrophic factor (BDNF) is synthesized as a precursor, namely proBDNF, which can be processed into mature BDNF (mBDNF). Evidences suggest that proBDNF signaling through p75 NTR may account for the emergence of neurological disorders. These findings support the view that the relative availability of mBDNF and proBDNF forms is an important mechanism underlying brain circuit formation and cognitive functions. Here we describe novel insights into the proBDNF/p75 NTR mechanisms and function in vivo in modulating neuronal circuit and synaptic plasticity during the first postnatal weeks in rats. Our results showed that increased proBDNF/p75 NTR signaling during development maintains a depolarizing γ-aminobutyric acid (GABA) response in a KCC2-dependent manner in mature neuronal cells. This resulted in altered excitation/inhibition balance and enhanced neuronal network activity. The enhanced proBDNF/p75 NTR signaling ultimately led to increased seizure susceptibility that was abolished by in vivo injection of function blocking p75 NTR antibody. Altogether, our study shed new light on how proBDNF/p75 NTR signaling can orchestrate the GABA excitatory/ inhibitory developmental sequence leading to depolarizing and excitatory actions of GABA in adulthood and subsequent epileptic disorders.
Introduction
The brain-derived neurotrophic factor (BDNF) is an activitydependent secreted synaptic molecule that plays an important role in brain development and synaptic plasticity (Park and Poo 2013) . BDNF is synthesized as a 32-kDa precursor (proBDNF) that can be processed "intracellularly" to the 14-kDa mature form (mBDNF) by furin, or by extracellular plasmin or matrixmetalloprotesase-7 once secreted Yang et al. 2009 ). ProBDNF and mBDNF are assumed to produce opposing physiological responses mediated by the activation of 2 distinct classes of transmembrane receptors, the p75 NTR and the TrkB, respectively (Lu et al. 2005) . The proteolysis of the precursor (proBDNF) is crucial for cognitive functions (Lu 2003; Bramham and Messaoudi 2005; Cohen-Cory et al. 2010) . Likewise, both in human and animal models accumulating evidences indicate that impairment of proBDNF processing may account for the emergence of neurodevelopmental and neurodegenerative disorders, including schizophrenia, autism, and seizures (Binder et al. 2001; Carlino et al. 2011; Garcia et al. 2012) . Altogether, these findings support the view that biosynthesis of mBDNF and proBDNF forms is an important mechanism underlying brain remodeling and cognitive functions; thereby its impairment may lead to altered neuronal network remodeling and subsequently to severe and highly prevalent neurological diseases. Interestingly, BDNF upregulation has been involved in the development of epilepsy (McNamara and Scharfman 2012; Puranam et al. 2015) but recent evidence also indicates that the proBDNF and p75 NTR expression increases in both neurons and glia after seizures (Unsain et al. 2008; Volosin et al. 2008; Cragnolini et al. 2009; VonDran et al. 2014) . In the latter study, this increased level of proneurotrophins to seizures occurs independently of cell death (VonDran et al. 2014) . These observations suggest that proneurotrophins may participate to the mechanisms of epileptogenesis. However, it is currently unknown how the proBDNF/p75 NTR signaling might be involved. Abnormalities in inhibitory synaptic neurotransmission have also been linked to epileptic activity (Kaila et al. 2014) . Moreover, under epileptic conditions, depolarizing and excitatory γ-aminobutyric acid (GABA)ergic responses, sustained by a decrease of the K + -Cl − co-transporter KCC2 activity, have been reported (Rivera et al. 2004; Huberfeld et al. 2007; Pathak et al. 2007; Blaesse et al. 2009; Bragin et al. 2009; Ben-Ari et al. 2012; Shulga et al. 2012; Kahle et al. 2014; Pallud et al. 2014) . Due to the primordial role of neurotrophins in brain development and plasticity, the question of whether and how proBDNF/p75 NTR signaling affects GABAergic neurotransmission could be of clinical significance. Furthermore, the expression patterns of proBDNF and p75 NTR within the first postnatal weeks suggest that they play an important role in modulating neuronal circuits during this critical developmental time window (Menshanov et al. 2015) . Similarly, the strength and polarity of GABA A receptor-mediated responses is developmentally regulated, through notably KCC2 function Rivera et al. 1999) . Altogether, this suggests that an interplay between proBDNF/p75 NTR and GABAergic neurotransmission is at play to shape early neural circuitry and synaptic plasticity. This also suggests that imbalance of pro-and mature BDNF effects may then lead to an impaired neuronal network and to the emergence of neurological disorders at adulthood. The present study aims at elucidating how increased levels of proBDNF during the developmental period leads to the emergence of pathological disorders at later stages. Our results provide the first compelling evidence that proBDNF disrupts the GABA excitatory/inhibitory developmental sequence leading to depolarizing and excitatory actions of GABA in adulthood, which then favors the emergence of epileptic disorders.
In Utero Electroporation
In utero injections and electroporations were performed as previously described (Carabalona et al. 2012) in embryos from timed pregnant rats (embryonic day 15) that were anaesthetized with ketamine (100 mg/kg)/xylazine (10 mg/kg). Wistar rats (Janvier, France) were raised and mated at INMED Post Genomic Platform (PPGI) animal facility in agreement with the European Union and French legislations. Briefly, the uterine horns were exposed, and a lateral ventricle of each embryo was injected using pulled glass capillaries and a microinjector (PV820 Pneumatic PicoPump, World Precision Instruments) with Fast Green (2 mg/mL; Sigma, St. Louis, MO, USA) combined with the following DNA constructs encoding green fluorescent protein (GFP) and/or CR-proBDNF and/or Cl-Sensor (ratio 1:2). Plasmids were further electroporated by discharging a 4000 μF capacitor charged to 40 V with a BTX ECM 830 electroporator (BTX Harvard Apparatus, Holliston, MA, USA). The voltage was discharged in 5 electrical pulses at 950 ms intervals via tweezer-type electrodes (Nepa Gene Co, Chiba, Japan) placed on the head of the embryo across the uterine wall. We performed in utero electroporation in embryonic rats at E15, corresponding to an active period of both radial and tangential migration of newborn neurons in the cortex. Following experimentation, morphological analysis of electroporated tissues, selected by GFP expression under fluorescent stereomicroscope (Olympus SZX 16), was performed. The criteria commonly used for exclude animals were localization and cell density of transfected cortices and absence of abnormal cortex morphology (i.e. cortical disruption, thickening and abnormal cortical organization). Our analyses revealed no alterations in cortical layer position or morphology in GFP and CR-proBDNF conditions, although we cannot exclude the possibility that proBDNF impact the neuronal cells at the cellular and subcellular levels. Nevertheless, approximately 20% of electroporation failed due to the absence of transfected cells as revealed by the lack of fluorescent cells (in GFP and CR-proBDNF conditions). These animals were excluded from the study.
BDNF Immunoassay
Electroporated zones of the somatosensory cortex and hippocampal tissues were homogenized in RIPA buffer (150 mM NaCl, 1% Triton X100, 0.1% SDS, 50 mM Tris HCl), pH 8, containing protease inhibitors (Complete Mini; Roche). Lysates were centrifuged (10.000 g for 30 min at 4°C). Loading was 200 µg of proteins as determined using a modified Bradford reaction (BioRad Laboratories). Quantification of mature-and proBDNF was performed with both proBDNF and mature BDNF Rapid ELISA Kit (Biosensis Pty Ltd., Thebarton, SA, Australia) in the concentrated solutions following the manufacturer's protocol. Experiments and analysis were done blind.
Western Blotting
Electroporated zones of the somatosensory cortex were homogenized in RIPA buffer (150 mM NaCl, 1% Triton X100, 0.1% SDS, 50 mM Tris HCl), pH 8, containing protease inhibitors (Complete Mini; Roche). Lysates were centrifuged (10.000 g for 10 min at 4°C) and the supernatant was heated at 90°C for 5 min with Laemmli loading buffer. Loading was 20 µg of proteins as determined using a modified Bradford reaction (BioRad Laboratories). Proteins were separated in 7-15% SDS-PAGE and electrophoretically transferred to nitrocellulose membranes. Membranes were blocked with 5% bovine serum albumin (BSA) in TBS 0.1% Tween 20 (TBST) for 2 h at RT, then incubated with primary antibodies diluted in TBST containing 3% BSA overnight at 4°C or 2 h at RT. Blots were probed with antibody against KCC2 (1:2000; rabbit, US Biological), T4-NKCC1 (1:1000; mouse, Chemicon), p75 NTR (1:1000; mouse, biosensis), and tubulin (1:10.000; ß-tubulin, mouse, Sigma). After washing with TBST, membranes were incubated with HRP-conjugated secondary antibodies diluted in TBST containing 3% BSA for 60 min, washed with TBST and then developed using the G:BOX gel imaging system (Syngene). The appropriate exposure time of the digital camera for acquisition of chemiluminescent signals from immunoblots was adapted to avoid saturated pixels and expression levels were estimated by Image J software (NIH, Bethesda, MD; http://rsb.info.nih.gov/ij/).
Immunocytochemistry and Confocal Microscopy
Under deep anesthesia with isoflurane prior to chloral hydrate (7% in PBS 1 M), P10 to P30 electroparated rats were intracardially perfused with cold PBS (1 M) followed by 4% PFA in PBS.
Brains were removed, post-fixed overnight at 4°C and rinsed in PBS. Coronal cortical sections (70 μm thick) were obtained using a vibratome (Microm HM 650 V). Sections were incubated first for 1 h in PBS with 1% BSA and 0.3% Triton X-100, then overnight at 4°C with chicken anti-proBDNF (1:000; AB9042; Chemicon) or rabbit anti-p75 NTR (1:500; AB1554; Millipore) or rabbit anti-caspase-3 cleaved (1:500; 9661 S; Cell Signaling) or rabbit anti-panKCC2 (1:4000; non commercial) or mouse antiNeuN (1:1000; MAB377; Chemicon). Sections were rinsed in PBS and incubated for 2 h with the corresponding Cy5 or Cy3-conjugated secondary antibodies diluted in PBS (1:1000; Chemicon). DAPI staining was applied for nuclear localization (Vector Laboratories H-1200). Control tissues used to determine the level of nonspecific staining included tissues incubated without primary antibody. KCC2 antibody specificity has been previously validated with control preimmune sera and in tissues of KCC2 KO animals (Ludwig et al. 2003) . The specificity of the p75 NTR antibody has been verified in neurons of p75 NTR KO animals (Shulga et al. 2012) . In all cases, no specific staining was observed. Sequential acquisition of immunoreactivity of GFP positive pyramidal-like cells was performed using laser scanning confocal microscope (Zeiss LSM 510 Meta) with a 40× or 63× oil-immersion objectives. In each set of images, laser light levels and detector gain and offset were adjusted to avoid any saturated levels. Optical sections were digitized (1024 × 1024 pixels) and processed using Image J software (W.S. Rasband, National Institute of Health).
Quantification
KCC2 analysis was performed in blind. Intensity analyses of KCC2 fluorescence were performed using 40× objective and Fiji software. The total fluorescence intensity analysis has been normalized to the number of cells contained in the ROIs. The 3D object counter plugin from Fiji software was used to count the number of cells. The mean values and the calculated standard error of the mean (SEM) (error bars) were represented for each group.
Relative Quantitative Expression of mRNA Transcripts
Expressions of p75 NTR , NKCC1, and KCC2 mRNA in the electroporated regions of the somatosensory cortex were measured by real-time quantitative RT-PCR. Total RNAs were isolated from cerebral cortices (P20 rats) using Mini RNeasy kit (Qiagen) then converted to cDNA using 1 µg RNA and a QuantiTect Reverse Transcription kit (Qiagen) according to manufacturer's instructions. PCR was carried out with the LightCycler 480 SYBR Green I Master (Roche Applied Science) with 1 µL cDNA using the following oligonucleotides (QuantiTect Primer Assays, Qiagen): p75 NTR (Ngfr; QT00181874), KCC2 (Slc12a5; QT01792413), NKCC1 (Slc12a2; QT00187173), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; QT001199633). Quantitative RT-PCR was performed with a Roche LC480 Light Cycler (Roche Applied Science) following the manufacturer's instructions. Relative mRNA values were calculated using the LC480 software and GAPDH as the housekeeping gene. PCR was performed in replicates of 3.
Slices Preparation
Somatosensory electoporated cortical slices identified by the atlas of Paxinos and Watson (Paxinos and Watson 2005) were prepared from P30 rats in ice-cold (2-4°C) oxygenated modified artificial cerebrospinal fluid (ACSF) (0.5 mM CaCl2 and 7 mM MgSO4; NaCl replaced by an equimolar concentration of choline). Slices (400 µm thick) were cut with a Vibratome (VT1000E; Leica, Nussloch, Germany) and kept at room temperature (25°C) for at least 1 h before recording in oxygenated normal ACSF containing (in mM): 126 NaCl, 3.5 KCl, 2 CaCl 2 , 1.3 MgCl 2 , 1.2 NaH 2 PO 4 , 25 NaHCO 3 and 11 glucose, pH 7.4 equilibrated with 95% O 2 and 5% CO 2 . Slices were then transferred to a submerged recording chamber perfused with ACSF (3 mL/min) at 34°C.
Spiking Activity and Data Analysis
Extracellular field-potential recordings were performed on acute electroporated somatosensory cortical slices using metal electrodes of 50 µm diameter (California Fine Wire, Grover Beach, CA, USA), positioned in the LV/VI cortical pyramidal cell layer of the transfected area. Field potentials were recorded using a DAM80 Amplifier (World Precision Instruments, Sarasota, FL, USA) using a 1-3 Hz bandpass filter and analyzed offline with the Axon package MiniAnalysis program (Jaejin Software, Leonia, NJ, USA) and Origin 5.0 (Microcal Software, Northampton, MA, USA). To determine the developmental changes in the GABA A signaling, we used isoguvacine, a potent, and selective GABA A receptor agonist (Krogsgaard-Larsen and Johnston 1978) . Unlike GABA, isoguvacine does not bind to the GABA B receptors (Bowery et al. 1983) . We determined the effect of isoguvacine on spiking frequency as a ratio of the spiking frequency at the peak of the isoguvacine response to the spiking frequency in control. Data obtained from 2 slices per animal were averaged before statistical analysis (n = 6 animals for each group).
In Vivo Electrophysiological Recordings
Cortical electroencephalographic (EEG) recordings were performed in freely moving rats. To implant recording electrodes, rats were anaesthetized with 4.5% isoflurane and maintained at 2.5%, placed in stereotaxic frame and prepared for aseptic surgery. A hole was drilled 2 mm posterior and 1.5 mm right to bregma. A screw connected to EEG transmitter was placed in the skull, and reference electrode was placed rostrally in the cerebellum. The screws were attached to the skull with dental cement and scalp closed. After surgery, rats were kept warm and received saline (0.9% NaCl, s.c.), and analgesic buprenorphine (0.03 mg/kg, s.c.) was administrated to minimize animal pain after surgery. After a 48 h recovery, EEG (amplified (1000×), filtered at 0.16-97 Hz pass, acquired at 500 Hz) was monitored using a telemetric system (Data Sciences International, St. Paul, MN) for 5 days, 24 h per day; food and water were given ad libitum. Recordings were analyzed offline using Spike2 8.0. Tonic seizures were defined on the EEG as single or multiple 5-30 Hz poly-spike of 5-folds SD amplitude and 10-30 s duration.
Non-Invasive Monitoring of Intracellular Chloride
To perform a non-invasive monitoring of [Cl − ] i we used a ratiometric genetically encoded Cl − -sensitive probe called Cl-Sensor (Markova et al. 2008; Waseem et al. 2010 ) that was co-expressed into the cells of interest together with other constructs as described above. The acquisition of fluorescence images was performed using a customized imaging set-up and consecutive cells excitation at 430 and 500 nm as described previously (Friedel et al. 2013) . The frequency of acquisition was 0.05 Hz. The duration of excitation was selected for each cell type and was selected to avoid use-dependent bleaching of the signal as described (Friedel et al. 2013 ).
Cl

− -Sensor Fluorescence Recordings from Brain Slices
Experiments were performed on acute cortical slices derived from in utero electroporated rat pups on postnatal days P10 and P30. Electroporated cortical regions of the P10 rat were identified using an atlas of the developing rat brain (Khazipov et al. 2015) . Electroporated cortical regions of the P30 rat were identified using the Paxinos and Watson rat brain atlas (Paxinos and Watson 2005) . Based on these 2 atlases, the somatosensory regions were used for acute slice experiments. Individual slices were transferred to a specially designed recording chamber where they were fully submerged and superfused with oxygenated ACSF complemented with 1 µM TTX, 1 µM strychnine, and 10 µM NBQX to prevent spontaneous neuronal activity and noncontrolled [Cl − ]i changes at 30-32°C at a rate of 2-3 mL/min. The applications of the ACSF solution containing isoguvacine (10 µM) or KCl (25 mM) + isoguvacine (10 µM) were performed with a perfusion system. The recovery of fluorescence after Cl − overload produced by KCl + isoguvacine was recorded in ACSF containing 10 mM bicuculline in addition to the abovementioned blockers to avoid Cl − efflux through GABA A R. Data obtained from 2 to 3 slices per animal were averaged before statistical analysis (n = 5 animals for each group).
Seizure Induction with Pentylenetrazol
To evaluate the susceptibility to seizures in controls rats (GFP-transfected brains) and in CR-proBDNF animals at P30, pentylenetrazol (PTZ) (25 mg/kg; Sigma) was administered via intraperitoneal injections every 10 min until generalized seizures occurred. Male rats were placed in a plexiglass cage and the time to the onset of the generalized seizure was videorecorded. There was no significant difference in weight between groups of animals. Experiments were blind: the phenotype of animals was established by morphological analysis after PTZ induction.
Rat Model of Temporal Lobe Epilepsy
About 6-week-old male rats were treated with pilocarpine hydrochloride (360 mg/kg, i.p.; Sigma-Aldrich) 30 min after scopolamine methyl nitrate (0.5 mg/kg, i.p.; Sigma-Aldrich). This pilocarpine dose was chosen because it elicited the most severe seizures with limited mortality, as previously described by other investigators (Esclapez et al. 1999 ). Animals were continuously monitored to identify the onset of "Status Epilepticus" (SE). Pilocarpine injections resulted in continuous, repetitive behavioral seizures (defined as SE). Behavioral rating of seizures used the Racine scale (Esclapez et al. 1999; Lüttjohann et al. 2009 ). The onset of SE was defined as the time when animals experienced continuous stage 5 seizures on Racine scale. Rats that did not fulfill these criteria for SE were not included in analyses. After 3 h of SE, convulsions were treated with diazepam (8 mg/kg, i.p.; Roche) and 1 mL of saline solution (0.9% NaCl; Sigma-Aldrich) was administrated subcutaneously for rehydratation of the animals. The injection of diazepam was repeated as needed to help terminate behavioral seizures up to 12 h after the end of SE.
P75 NTR Blocking Antibody Infusion
Osmotic minipumps and cannulae were implanted to focally and continuously deliver a p75 NTR functional blocking antibody (p75 NTR Ab; 1:500; AB1554; Millipore) to the somatosensory cortex for the PTZ experiment in electroporated rats or to the dorsal, left dentate gyrus (DG) for the pilocarpine induction experiment. As concerning the somatosensory cortex, this region was targeted for antibody infusion since from our histological observations this was the region electroporated with GFP or CR-proBDNF. Under epileptic conditions the DG undergoes important reactive plasticity, where ectopic dentate granule cell (DGC) axons sprout and create a reverberant excitatory circuit between DGCs. This is involved in the formation of epileptiform bursts in patients with temporal lobe epilepsy (TLE) as well as in animal models (Tauck and Nadler 1985; Represa et al. 1989; Frotscher, 1989; Sutula et al., 1989; Golarai et al., 2001; Gabriel et al. 2004; de Lanerolle et al. 2012; Peret et al. 2014) . Hence, few studies have shown that the DG exhibits KCC2 downregulation and proBDNF/p75-NTR upregulation in animal models of TLE (Pathak et al. 2007; Volosin et al. 2008; Barmashenko et al. 2011; Bischoff et al. 2012; Kourdougli et al. 2015) . Thus, to assess the effect of blocking p75 NTR signaling under epileptic conditions, the DG appear to be a good target. For surgery, rats were anaesthetized with 4.5% isoflurane and maintained with 2.5% isoflurane for surgery. Rats were placed ProBDNF-Mediated p75 in a stereotaxic apparatus, a scalp incision was made, and a 0.8 mm diameter hole was drilled through the skull (cortex: A/P +1; L/M −3; D/V −1 or DG: A/P −3.8; L/M +2.5; D/V 3.0) and a 3.0 mm long 28 gauge cannula (Alzet brain infusion kit, Charles River) was inserted and secured to the skull with dental cement. An osmotic minipump (Alzet minipumps 2002, Charles River) and tubing connected to the cannula were implanted subcutaneously over the back. Minipumps contained vehicle solution containing PBS (1 M, pH 7.4) supplemented with IgG (rabbit; 1:500; sc-2027; Santa Cruz) or p75 NTR Ab solution containing a p75 NTR functional blocking antibody diluted (rabbit;
1:500; AB1554; Millipore) in PBS (1 M, pH 7.4). After surgery, rats were kept warm, received saline (0.9% NaCl, s.c.), and analgesic buprenorphine (0.03 mg/kg, s.c.) was administrated to minimize animal pain after surgery. In all experiments, infusions began at 2 days post-SE and last for 5 days with a delivery rate of 0.5 μL/h ± 0.05 μL at body temperature. Immunohistochemical detection of p75 NTR Ab-infused brains was performed on fixed coronal sections by incubating the tissues for 30 min at room temperature with an Alexa Fluor 488-anti-rabbit (1:1000; FluoProbes). Acquisition of immunoreactivity was performed using a widefield fluorescence microscope (Zeiss, Apotome 2) with a 10× objective.
Statistical Analysis
If not stated otherwise, statistics are presented as the mean ± the SEM. Experiments with control and proBDNF animals were processed at the same time to ensure homogeneity of experimental conditions. Statistical analyses and assessment of normal distribution (Kolmogorov-Smirnov test) were performed with GraphPad Prism (GraphPad software 5.01). A 2-tailed, unpaired Student's t-test was used to examine the statistical significance of the differences between 2 independent groups in ELISA, microcopy, Western blotting and qRT-PCR experiments. A 2-tailed, paired Student's t-test was used to analyze differences within one group across conditions (i.e. spiking frequency before and during isoguvacine application). The nonparametric Mann-Whitney U test was used for EEG and the Kruskal-Wallis 1-way ANOVA test was used for Cl-Sensor experiments. The 1-way ANOVA all-Tukey test was used to compare multiples groups. The statistical significance level, alpha value was 0.05. Significantly different values (*P < 0.05; **P < 0.01; ***P < 0.001) are indicated in figures with asterisks.
Results
Cortical Expression of CR-proBDNF
Recent studies have shown that proBDNF is the most abundant isoform expressed in the immature cortex (Perovic et al. 2013; Menshanov et al. 2015) . These findings suggest that proBDNF may play an important role in the developing brain. In order to evaluate the functions of proBDNF in vivo, a proteolytic cleavage-resistant proBDNF (CR-proBDNF), that contains a mutated proconvertase/furin cleavage site, was synthesized (GeneCust, France) by replacing arginine with alanine ( Fig. 1A) , and previously validated in vitro (Riffault et al. 2014) . We next inserted the proBDNF mutated sequence in a bicistronic plasmid vector coexpressing CR-proBDNF-Cherry and GFP, under the control of 2 ubiquitin promoters (Fig. 1A) . We used in utero electroporation of plasmids to express GFP, as a control, or GFP-CR-proBDNF-Cherry (referred as CR-proBDNF) in the neocortex at embryonic day 15 (E15). At that stage, pyramidal neurons of the deep layers of the cortex (layers V/VI) are mainly targeted (Kriegstein and Noctor 2004) . Coronal sections through the somatosensory cortex of GFP and CR-proBDNF electroporated brains from P10 to P30 rats were immunolabeled for NeuN, a neuronal marker to assist in the histological identification of cortical layers (Fig. 1B,C) . In CR-proBDNF brains, the GFP and Cherry fluorescence intensity profiles showed no differences in the layering of the fluorescent cells when compared with control GFP-expressing neurons (Fig. 1C) . Thus GFP and CR-proBDNF positive neurons electroporated at E15 most likely represent deep layers neurons (layers V/VI). These data indicates that proBDNF did not alter the migration of pyramidal neurons. Moreover, our plasmid vector allowed us to identify the electroporated cells that co-expressed CR-proBDNF-Cherry and GFP and "recipient neurons" that are negative for GFP and express CR-proBDNF-Cherry alone (Fig. 1C3, 6 , and 9) (Horch and Katz 2002) . These results suggest that CR-proBDNF could also act in a paracrine manner to affect nearby neurons.
The Expression of the Receptor-Ligand Complex proBDNF/p75 NTR is Increased in CR-proBDNF
Electroporated Cortex
To confirm that mutation of the proteolytic cleavage site prevents conversion of proBDNF into mBDNF, we measured the levels of proBDNF expression in cortical neurons by using primary antibodies directed against the precursor form of the BDNF (proBDNF). The intensity of immunostaining for proBDNF was significantly increased in CR-proBDNF electroporated cortex (297.22 ± 9.46% of proBDNF intensity compared with GFP control tissues; P < 0.001; Fig. 2A,B) . We next measured the concentration of proBDNF in cortical tissues in control, GFP and in the ipsilateral, electroporated cortex and contralateral, nonelectroporated cortex of CR-proBDNF rats at P20 using an ELISA proBDNF immuno-detection assay. As illustrated in Figure 2C , proBDNF levels in the ipsilateral hemisphere of CR-proBDNF rats increased significantly (239 ± 4 pg/mL) compared with the contralateral hemisphere (134 ± 3 pg/mL) or with control (125 ± 1 pg/mL) or with rats electroporated with GFP (119 ± 5 pg/ mL; P < 0.01). To further examine whether the CR-proBDNF affected the concentration of mature BDNF (mBDNF) in cortical tissues, we carried out a quantification of mBDNF at P20 from GFP-and CR-proBDNF-electroporated brains. Our results demonstrate that the level of mature BDNF was not significantly different in CR-proBDNF rats (136 ± 7 pg/mL) compared with GFP control rats (124 ± 25 pg/mL; P > 0.05; Fig. 2D ). We have recently demonstrated that endogenous or exogenous accumulation of proBDNF triggers an upregulation of p75 NTR expression in a positive feedback mechanism operating between proBDNF and its receptor (Riffault et al. 2014) . In this study, we have used p75
NTR expression levels as a biological marker for the release of proBDNF. As observed for proBDNF immunostaining, we found that the intensity of staining for p75 NTR was robustly increased in CR-proBDNF (342.11 ± 5.82% of p75 NTR intensity compared with GFP control tissues; P < 0.001; Fig. 2E,F) . To confirm the increase of p75 NTR proteins in CRproBDNF tissues, Western blotting analysis was performed on cortical neuronal lysates. We found that proBDNF induces an increase in the total amount of p75 NTR proteins (135.29 ± 1.2%; P < 0.05; compared with control; Fig. 2G ). To investigate whether proBDNF would also regulate p75 NTR gene expression, p75 NTR mRNA levels were measured using qRT-PCR. As illustrated in Figure 2H , CR-proBDNF electroporated cortices show a significant increase of p75 NTR mRNA levels (GFP: 7.62 ± 0.21 A.U.; n = 5 vs. CR-proBDNF: 20.07 ± 0.59 A.U.; P < 0.05; Fig. 2H ).
The importance of both mature and pro-forms of BDNF in the regulation of cortical cell survival (Canals et al. 2001; Menshanov et al. 2015) suggest that an increase in the expression of p75 NTR and changes in the levels of proBDNF could underlie a decrease in the number of cortical neurons. In an attempt to identify a possible decrease in the density of cortical neuron, we quantified the cortical cell number using the expression of the mature neuronal marker NeuN at P20. The density of NeuN-positive cells was not different between CRproBDNF and GFP electroporated brains (35.8 ± 3.9 vs. 36.1 ± 3.6 NeuN-positive cells/100 µm 2 , respectively; P > 0.05; Fig. 2I,J) . Thus, the present data indicates that cortical tissues electroporated with CR-proBDNF construct show a significant increased expression of the precursor form of BDNF (proBDNF) and its high-affinity pro-neurotrophin receptor p75
NTR . In addition, this increased number of proBDNF and p75 NTR positive cells was observed without reduction of cortical neuron density.
The Chloride Exporter KCC2 is Downregulated in the Cortex of proBDNF Rats
The developmental excitatory-inhibitory GABA sequence mediated by the upregulation of KCC2 is closely paralleled by the downregulation of proBDNF and p75 NTR expression in cortical regions (Ben-Ari et al. 2007; Menshanov et al. 2015) . Furthermore, an interplay between depolarizing GABA, the KCC2/NKCC1 imbalance, and p75 NTR has previously been shown after neuronal injury (Shulga et al. 2012 ). These observations led us to investigate whether developmental proBDNF/p75 NTR signaling can modulates KCC2 expression. We first analyzed the expression of KCC2 and NKCC1 at both mRNA and protein levels in CR-proBDNF rats. NKCC1 mRNA extracted from electroporated cortices at P30 shows similar levels of NKCC1 transcripts when compared with GFP control animals (7.98 ± 1.09 in CR-proBDNF vs. 8.06 ± 0.68; P > 0.05; Fig. 3A ). In contrast, KCC2 mRNA levels are downregulated in CR-proBDNF rats (1.82 ± 0.43 in CR-proBDNF vs. 2.40 ± 0.34; P < 0.05; Fig. 3A) . The NKCC1 and KCC2 proteins as measured by western blotting followed the mRNAs levels. Thus, in CRproBDNF animals the NKCC1 protein remains unchanged when compared with control GFP (105.32 ± 2.76% compared with control, P > 0.05; Fig. 3B ), whereas KCC2 expression was significantly reduced by 20% of the control GFP (79.31 ± 4.37% compared with control, P < 0.05; Fig. 3B ). We next analyzed whether the overall neuronal expression of KCC2 is altered in CR-proBDNF electroporated cortices. To this end, we performed KCC2 immunolabeling (Fig. 3C ) and analyzed at P30 the fluorescence intensity of KCC2 in GFP and CR-proBDNF electroporated neurons. The average KCC2 fluorescent intensity in CR-proBDNF animals was significantly reduced when compared with control GFP (2859.01 ± 119.36 A.U. CR-proBDNF vs. 1729.60 ± 62.17 A.U., P < 0.001; Fig. 3D ). Taken together, our qRT-PCR, immunoblot, and immunofluorescence results demonstrate that proBDNF decreased KCC2 levels in neuronal cells.
The Developmental GABA Excitatory to Inhibitory Shift is Abolished in the Presence of proBDNF
Cortical GABAergic excitation contributes to epileptic activities (Kaila et al. 2014; Pallud et al. 2014) . This increased cell excitability could be sustained by a lower expression of KCC2 that leads to higher neuronal [Cl − ] i and derived GABA A receptor-mediated depolarization instead of hyperpolarization (Nabekura et al. 2002; Rivera et al. 2004; Boulenguez et al. 2010; Conti et al. 2011; Friedel et al. 2015) . To test whether proBDNF/p75 NTR signaling also altered Cl − homeostasis, constructs encoding Cl-Sensor plus scrambled shRNA (control) or Cl-Sensor plus CR-proBDNF were electroporated in utero in rats at E15 (see Methods for details; Fig. 4A ). Transverse slices of cortex were prepared at postnatal days P10 and P30. Electroporated slices harbored hundreds of neurons expressing Cl − -Sensor in cortical layers V/VI, which exhibited variable absolute values of R 430/500 . Despite the observed variability in absolute values, bath application of isoguvacine (10 µM, 3 min) to P10 CR-proBDNF and control slices produced a uniform decrease of R 430/500 (indicated by an arrow in Fig. 4B and by the negative value of ΔR/R in Fig. 4C ) in approximately 80% of fluorescent neurons, reflecting a decrease in [Cl − ] i characteristic of depolarizing action of GABA. Bath application of isoguvacine (10 µM, 3 min) to P30 control slices showed an increase of R 430/500 (0.174 ± 0.044 A.U, Fig. 4C ), characteristic of a 
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− ion influx (indicated by an arrow in Fig. 4B and by the positive value of ΔR/R in Fig. 4C ) into the cell indicating that GABA switched from depolarizing to hyperpolarizing actions. As compared with control, CR-proBDNF slices at P30 showed a reduction of R 430/500 (−0.076 ± 0.004%; P < 0.05), suggesting that the conversion of GABA-induced depolarization into hyperpolarization is impaired (indicated by an arrowhead in Fig. 4B and by the negative value of ΔR/R in Fig. 4C ). ] i that recovered progressively to the control values after isoguvacine washout (Fig. 4D) . In mature P30 slices expressing CR-proBDNF, the half-recovery time was significantly longer than those measured in slices expressing control GFP (1.83 ± 0.25 min and 1.00 ± 0.10 min, respectively; F Value = 6.7; P < 0.01; Fig. 4E ). These results suggest that in vivo CR-proBDNF downregulates KCC2-dependent neuronal Cl − extrusion that maintains a depolarizing shift in GABA activity in mature neurons. 
ProBDNF-Mediated KCC2 Downregulation Leads to GABA Excitatory Activity in Mature Cortical Neurons
Our data indicated that KCC2 activity is downregulated in proBDNF condition, leading to elevated intracellular chloride. We next wanted to determine whether this effect is associated with excitatory or inhibitory actions at the network level. Indeed, GABA-induced depolarizing currents are not necessarily excitatory (Kirmse et al. 2015; Ben-Ari 2015a) and can inhibit neuronal activity through a shunting mechanism (Ben-Ari 2002). Thus, we evaluated whether the activation of GABA A receptor leads to neuronal excitation by performing field recordings of cortical slices at P30 in control (GFP) and CRproBDNF rats. To activate GABA A receptors (GABA A Rs) we bathapplied the selective GABA A R agonist isoguvacine (10 µM). In slices from GFP control group, isoguvacine invariably induced a decrease of spiking activity in field-potential recordings at P30 (−29.4 ± 12.2%; P < 0.05; Fig. 5A,B) . In contrast, in slices obtained from CR-proBNDF rats at P30, isoguvacine invariably induced an increase of spiking activity (+24.6 ± 10.7%, P < 0.01; Fig. 5A,B) . Our data therefore show that GABAergic transmission has excitatory action on cortical network at P30 in CR-proBDNF rats.
CR-proBDNF Rats Display Increased Susceptibility to PTZ-Induced Seizures
We next investigated whether overexpression of proBDNF may influence the susceptibility to seizures. CR-proBDNF and agematched control rats (transfected with GFP alone) at P30 were intraperitoneally injected with subconvulsive doses of PTZ (25 mg/kg) every 10 min. PTZ is known to induce seizures by reducing the GABA A receptor-mediated inhibition (Klioueva et al. 2001) . The susceptibility to PTZ is age-dependent and previous studies found that the lowest threshold for major seizures can be observed during the first 2 postnatal weeks of life and the highest at around P30 (Vernadakis and Woodbury 1969; Klioueva et al. 2001 ). These results suggest that the vulnerability of the developing neocortex to PTZ is correlated to the maturation of GABAergic system. Injections of PTZ were continued every 10 min until each rat had generated tonic-clonic seizure. Seizure susceptibility and severity were quantified with the canonical Racine's scale of seizure severity, including dose and latency to onset of the first minimal motor seizure and the first generalized tonic-clonic seizure. Generalized seizures in vehicle-treated CR-proBDNF rats occurred at significantly lower doses of PTZ (77.5 ± 2.5 mg/kg compared with 90.0 ± 5.5 mg/kg in control; F Value = 5; P < 0.05; Fig. 6B ) with a reduced interval between minimal and generalized seizures (1.42 ± 0.21 min compared with 8.06 ± 1.24 min in control; F Value = 7.6; P < 0.01; Fig. 6C ) and at significantly shorter latencies than they did in GFP control rats (23.91 ± 0.49 min compared with 31.87 ± 0.73 min in control; F Value = 13.11; P < 0.01; Fig. 6D ). In order to confirm the crucial role of p75 NTR signaling in hyperexcitability and subsequent seizure susceptibility, we infused intracortically (Fig. 6A for the experimental design) and continuously a p75 NTR functional blocking antibody (p75 NTR Ab) for 10 days using osmotic minipumps from P20, when pyramidal neurons are mature (Zhang 2004) , to P30 (Fig. 6E) . P75 NTR Ab-treated CRproBDNF rats showed PTZ seizure thresholds comparable to GFP control rats (cumulative dose: 100 ± 6.5 mg/kg, F Value = 0.04; interval: 8.44 ± 1.12 min, F Value = 0.01; mean latency: 35.74 ± 1.54 min, F Value = 1.63; P > 0.05 for all experiments when compared with control group; Fig. 6B-D) . Thus, our results demonstrate the key role of altered proBDNF/p75 NTR signaling in seizure susceptibility. We next performed immunohistological analysis of KCC2 expression in vehicle-and p75 NTR Ab-treated CR-proBDNF rats at P30. The average KCC2 fluorescent intensity was significantly lower in vehicle-treated CR-proBDNF rats (1290.3 ± 51.9 A.U) as compared with the KCC2 staining in p75 NTR Ab-treated CR-proBDNF rats (1707.2 ± 120.8 A.U., P < 0.01;
Fig. 6F-H).
Seizures are reported to cause apoptotic neuronal death and given the proapoptotic function established for p75 NTR (Volosin et al. 2008; Friedman 2010) , we wanted to investigate whether PTZ-induced seizure increases apototic neurodegeneration in cortical neurons in CR-proBDNF rats. To this end, we performed immunohistochemical analysis for cleaved caspase-3, a marker for cell apoptosis (Logue and Martin 2008) , and quantified the ratio of cleaved caspase-3 neurons per surface area. A comparison of the number of cleaved caspase-3-positive neurons before PTZ injection showed that the number of apoptotic neurons did not increase in CR-proBDNF animals (107 ± 14%; P > 0.05, compared with control; Fig. 6I,J) . We next found that PTZ-induced seizure significant increased the expression of cleaved caspase-3 in cortical neurons in GFP rats (158 ± 9%; P < 0.05, compared with control; Fig. 6I ,J) and this effect is amplified in the vehicletreated CR-proBDNF group (179 ± 7%; P < 0.05, compared with control; Fig. 6I,J) , whereas, the pretreatment with p75 NTR Ab abolished the effect of PTZ in CR-proBDNF rats (108 ± 4%; P > 0.05 compared with control; Fig. 6I,J) . Together, our results indicated that reduced seizure threshold in CR-proBDNF rats could result from a downregulation of KCC2 triggered by the proBDNF/p75 NTR signaling pathway. In addition, these results demonstrate that p75 NTR Ab infusion restored the levels of seizure risk back to levels seen in GFP control rats and can prevent some of the deleterious effect of seizure and neuronal degeneration induced by PTZ.
Early p75 NTR Ab Infusion Reduced Seizure Frequency
During the Chronic Phase of TLE
In an attempt to elucidate the role of proBDNF/p75 NTR signaling in spontaneous epileptiform discharges, we used the pilocarpine model of TLE, which is associated with an increased cellular levels of proBDNF and p75 NTR (Roux et al. 1999; Unsain et al. 2008; Volosin et al. 2008; Cragnolini et al. 2009; VonDran et al. 2014; Thomas et al. 2016) . We first measured the total proteins levels of the proBDNF in rat hippocampi following pilocarpine using ELISA assay. Rats were injected with saline or pilocarpine to induce SE and sacrificed at 2 days (d2) post-SE for hippocampal dissection. We show that proBDNF protein levels were significantly upregulated at d2 post-SE, confirming previous studies (Unsain et al. 2008; Volosin et al. 2008; VonDran et al. 2014) (Fig. 7B , saline-vs. pilocarpine-injected rats: 97.70 ± 5.51 vs. 320.71 ± 23.76; P < 0.001). We next investigated whether proBDNF/p75 NTR pathway is involved in the development of spontaneous seizures after pilocarpine-induced SE. Several electrographic studies have shown that the epileptogenic network in both patients and animal models of TLE is broad and multifocal, involving several subcortical and cortical structures such as the entorhinal cortex, the lateral and inferior cortices, the thalamus and other structures of the limbic system such as the amygdala, subiculum and the hippocampus (Clifford et al. 1987; Bertram 1997; Cohen et al. 2002; Bernhardt et al. 2012; Lévesque et al. 2012; Toyoda et al. 2013) . We then decided to infuse intrahippocampally a p75 NTR functional blocking antibody (p75 NTR Ab; Fig. 7C ) from d2 to d5 post-SE (Fig. 7A for the experimental design). We analyzed the seizure activity with telemetric scalp EEG recordings, during the chronic phase, at 2
ProBDNF-Mediated p75 months post-SE in vehicle-and p75 NTR Ab-treated rats. Ictal discharges, due to abnormal and long-lasting hypersynchronous neuronal activity, constitute the cardinal pathophysiological EEG activity in TLE. These spontaneous and recurrent ictal events lead to profound disabling clinical manifestations. Vehicle-treated rats displayed numerous ictal discharges (15.8 ± 1.25 per day) lasting 21.34 ± 0.87 s and including tonic and clonic phases (Fig. 7D,E) . These ictal events corresponded to the well-described tonic-clonic seizures with motor convulsions and loss of postural control. We observed a significant decrease in the number of ictal events in p75 NTR Ab-treated rats (P < 0.05; Fig. 7E ) without a significant decrease in their duration (P > 0.05). Finally, we examined whether the upregulation of proBDNF following SE induced a decrease in KCC2 expression as previously observed in CR-proBDNF rats (Fig. 7F) . We then performed analysis of KCC2 fluorescence intensity in vehicle-and p75 NTR Ab-treated rats at d5 post-SE within the CA3 region. The average KCC2 fluorescence intensity normalized to control was significantly lower in vehicle-treated rats at d5 post-SE as compared with the KCC2 staining in p75 NTR Ab-treated rats (0.38 ± 0.01 A.U vs. 0.94 ± 0.02 A.U, respectively, F Value = 52.7; P < 0.001; Fig. 7G ). Taken together, these experiments demonstrate that proBDNF/p75 NTR signaling is involved in KCC2 downregulation during epileptogenesis and plays a major role in the generation of ictal discharges in vivo in TLE.
Discussion
In the current study, we evaluated the actions of proBDNF in vivo using in utero electroporation of the rat neocortex at Figure 5 . Developmental excitatory-inhibitory GABA sequence is abolished in cortical neurons in CR-proBDNF rats. (A) Effects of isoguvacine (10 µM) in cortical slices from control (GFP) and CR-proBDNF rats: Representative traces of spontaneous extracellular field potentials recorded in cortical slices at P30 in control (GFP; left column) and CR-proBDNF rats (right column). (B) Average histograms of normalized spike frequency in rats at P30. Isoguvacine decreased the spikes frequency in control rats (to 29.4 ± 12.2%) and increased it in CR-proBDNF rats (to 24.6 ± 10.7%). Data were obtained from 2 slices recorded per animal from 6 rats for each group; *P < 0.05, **P < 0.01.
embryonic day 15 with a cleavage-resistant proBDNF. Our data obtained between postnatal days 10 and 30 in electroporated rat cortices demonstrated that proBDNF overexpression affects neuronal activity that resulted from a compromised GABAergic inhibition through the activation of the p75 NTR . As recently shown in the hippocampus, pharmacological inhibition of KCC2 can lead to seizure activity (Sivakumaran et al. 2015) . Moreover, both in animal models and human epileptic patients KCC2 downregulation results in an imbalance of excitation/inhibition levels and is correlated to the emergence of epileptiform activity (Huberfeld et al. 2007; Muñoz et al. 2007; Pathak et al. 2007; Shimizu-Okabe et al. 2011; Pallud et al. 2014) . In the present study, we show that proBDNF inhibits KCC2 expression and function in neuronal cells resulting in seizure susceptibility. Importantly, we show that functionally inhibiting p75 NTR rescued the KCC2 labeling pattern and attenuated the susceptibility to seizures. This is in line with previous studies showing that acute inhibition of the depolarizing action of GABA reduced interictal-like activity in models of TLE (Huberfeld et al. 2007; Muñoz et al. 2007; Bragin et al. 2009 ). Moreover, functional changes in GABA A receptor-mediated responses in developmental and pathological conditions paralleled the changes in the expression levels of p75 NTR (Nykjaer et al. 2005; Underwood and Coulson 2008; Blaesse et al. 2009 ). Altogether, our data suggest that depolarizing action of GABA A could be induced through proBDNF-mediated p75 NTR signaling. Finally, in order to confirm this hypothesis, we used the pilocarpine model of TLE and found that the application of a functional blockade of p75 NTR during the post-SE latent phase significantly reduced ictal discharges during the chronic phase of the pathology and restored KCC2 expression levels. These results suggest that proBDNF/p75 NTR may be an important effector of the seizure pathology and Before PTZ administration, overexpression of proBDNF (CR-proBDNF) did not increase the number of apoptotic neurons compared with control (CTR GFP). After PTZ administration, the level of cleaved caspase-3 positive neurons significantly increases in control and proBDNF conditions. Treatment with p75 NTR Ab abolished the increase in the number of apoptotic neurons promoted by PTZ administration. Data were obtained from 10 slices per condition from 3 rats for each group. *P < 0.05 and **P < 0.01 when compared with GFP control.
ProBDNF-Mediated p75 blockade of p75 NTR -induced GABA A -mediated depolarization can prevent some of the epileptogenic mechanisms.
Mature BDNF, proBDNF, and their receptors TrkB and p75 NTR , respectively, are widely expressed in the embryonic and developing CNS with highest levels during the first postnatal weeks, and are implicated in a number of critical processes in the coordination of neuronal network construction and synaptic plasticity. The highest levels of proBDNF are observed between postnatal days 8-15, whereas mature BDNF peaks at later stages, around postnatal day 15 Langlois et al. 2013; Winnubst et al. 2015) . About 2 recent studies demonstrated that in the immature neocortex and hippocampus, proBDNF is the predominant form of BDNF Menshanov et al. 2015) . Once secreted, proBDNF can be cleaved by extracellular proteases to yield the mature form. This extracellular conversion of proBDNF can be modulated under physiological conditions mainly determined by the level and/or pattern of synaptic activity, generated in the developing neuronal network Langlois et al. 2013) . Thus, the expression patterns of mature BDNF/TrkB to proBDNF/p75 NTR ratio during the developmental period are known to regulate the efficacy of GABAergic synaptic transmission (Langlois et al. 2013; Riffault et al. 2014) . Conversely, GABAergic activity triggers release of BDNF which in turn will fine-tune neuronal connectivity (Fiorentino et al. 2009; Kuczewski et al. 2009; Porcher et al. 2011) . Indeed, GABAergic transmission can be either excitatory or inhibitory, depending on the intracellular concentration of chloride (Kaila et al. 1993; Fritschy 2008; Ben-Ari et al. 2012) . Hence, GABAergic transmission is intimately linked on the expression levels of 2 majors cation-chloride cotransporters, NKCC1 and KCC2, acting in an opposite manner. These cotransporters are developmentally regulated (Rivera et al. 1999; Ben-Ari 2002; Dzhala et al. 2005; Sedmak et al. 2015) . The developmental switch from excitatory to inhibitory results from a KCC2-dependent increases in neuronal chloride extrusion beginning at postnatal days 6-8 in cortex (Stein et al. 2004; Khirug et al. 2005; Zhu et al. 2008; Khalilov et al. 2011 ) and GABA remains depolarizing until postnatal days 8-13 in rat cortical slices (Friedel et al. 2015) . The GABA developmental sequence has been confirmed in vitro across a wide range of animal species and brain strucutres (Ben-Ari 2015b; Oh et al. 2016; Valeeva et al. 2016) . The controversy regarding the polarity of GABAergic responses on slices came from 2 studies. The first study suggests that energy-deficiency results in the depolarizing action of GABA in glucose-perfused slices (Holmgren et al. 2010 ). However, this observation has been Data were obtained from 100 to 120 ROIs analyzed per condition from 3 rats for each group; ***P < 0.001.
contradicted by many groups (Ben-Ari et al. 2012) . The second study suggests that the slicing procedure damages neurons, hence leading to the accumulation of chloride and depolarizing action of GABA (Dzhala et al. 2012 ). Interestingly, 2 subsequent studies from the same authors have shown that the developmental shift in GABAergic response is independent of acute trauma caused by slicing procedure (Valeeva et al. 2013; Glykys and Staley 2016) . To date the depolarizing action of GABA in vivo has been observed by several groups using different techniques (Tyzio et al. 2008; Zhang et al. 2010; Kirmse et al. 2015) . Conversly, 2 recent publications suggest that in immature cortical neurons (≥P3) GABA in vivo can be depolarizing but exerts inhibitory network actions through the shunting mechanism (Kirmse et al. 2015; Valeeva et al. 2016) . Thus, the GABA developmental sequence in vivo remains an open question. This said, in the adult mammalian brain, there is a consensus concerning the inhibitory to excitatory shift of GABA A -mediated responses under various pathological conditions as observed both in vitro and in vivo . This shift arises from a compromised extrusion capacity and collapse of Clgradient due to KCC2 downregulation Sivakumaran et al. 2015; Ostroumov et al. 2016 ), as we also show here in adult experimental epilepsy. Our ex vivo experiments performed in cortical slices from GFP control rats showed that excitatory actions of GABA are found in immature neurons at postnatal day 10 whereas GABA responses were hyperpolarizing in mature neurons (i.e. postnatal day 30). In contrast, we found that activation of the GABA A receptor by isoguvacine, in mature proBDNF neurons (i.e. postnatal day 30) results in chloride efflux and increase in spiking activity. These results provide evidence supporting that activation of the proBDNF/p75 NTR signaling maintains depolarizing and excitatory action of GABA during development. The developmental function of proBDNF in immature cortex and by which intracellular cascades proBDNF/p75 NTR regulates KCC2 expression remains to be elucidated. Nevertheless, our study provides new findings on the potential role of proBDNF in regulating chloride homeostasis in a KCC2-dependent manner. In the neocortex, mature BDNF expression increases during development (Maisonpierre et al. 1990 ) and, via TrkB activation, promotes the expression of KCC2 (Ludwig et al. 2011) . Conversely, the developmental decrease of proBDNF (Menshanov et al. 2015) is correlated with upregulation of KCC2. Therefore, the mature BDNF to proBDNF ratio during the first postnatal weeks of life may also contribute to the developmental shift of GABA from depolarizing to hyperpolarizing. We found recently that accumulation of proBDNF induced upregulation of its receptor p75 NTR (Riffault et al. 2014) . This observation was confirmed in the present study, suggesting that epileptic seizures are correlated to proBDNF increase which in turn promotes the synthesis and expression of p75 NTR . Interestingly, it has also been described that in pathophysiological conditions, GABA-mediated depolarization can also lead to p75 NTR upregulation (Shulga et al. 2012) . Nevertheless, whether depolarizing actions of GABA is the cause or the consequence of the upregulation of the p75 NTR remains to be determined.
Prior studies have shown that proBDNF and p75 NTR were significantly elvevated in rats and mice, following pilocarpineinduced seizures (Unsain et al. 2008; Volosin et al. 2008; VonDran et al. 2014) . Recently, Thomas et al. (2016) demonstrated that increases in proBDNF following SE are due to the inhibition in the proteolytic conversion of proBDNF to mBDNF. Collectively, these results also suggest that proBDNF/p75 NTR signaling plays a significant role in mediating neuronal loss after seizures (Friedman 2010) . However, the observed increase of proBDNF and p75 NTR after seizures were also found in the absence of significant cell death (VonDran et al. 2014) . Thus, previous findings have indicated that sortilin functions as a coreceptor with p75 NTR for induction of apoptosis by proBDNF (Teng et al. 2005; Volosin et al. 2006) . It is likely that under pathological events proBDNF induces cell death in cells coexpressing sortilin and p75 NTR (Teng et al. 2005) . We confirmed the role of p75 NTR in mediating apoptosis by demonstrating that rats pretreated with the p75 NTR blocking antibody showed 61% reduction in neuronal death compared with vehicletreated rats after PTZ-induced seizures.
In addition, we provide evidences that endogenous proBDNF/ p75 NTR response following SE selectively downregulates KCC2 in the hippocampus which in turn leads to hyperexcitability. Clinical and experimental evidences indicate that impaired chloride extrusion resulting from decreased KCC2 expression can change GABA A receptor activation from hyperpolarization to depolarization and facilitate epileptiform discharges (Jin et al. 2005; Huberfeld et al. 2007; Pallud et al. 2014; Sivakumaran et al. 2015; Stödberg et al. 2015) . Thus, our findings strongly suggest that activation of p75 NTR by proBDNF following SE leads to a depolarizing action of GABA sustained by a selective deficit of KCC2 activity and contributes to epileptiform activites. Importantly, we show that early blockade of p75 NTR prevent some of the epileptogenic mechanisms such as by rescuing KCC2 expression and reducing network hyperexcitability.
Our results contrast with those of Grabenstatter et al. (2014) where intraperitoneal administration of a small molecule binding on p75 NTR prior to and at onset of SE, at a time point where p75 NTR was not upregulated, did not prevent or reduce the development of spontaneous seizures after SE (Grabenstatter et al. 2014) . Here, we have used osmotic minipumps to continuously deliver intrahippocampally a fonctionally blocking p75 NTR during early epileptogenesis, a time window previously demonstrated to harbor p75 NTR upregulation (VonDran et al. 2014) , resulting in a significantly reduced seizure frequency during the chronic phase of the pathology. Thus, this apparent discripency can account from different experimental design. Our data further suggest a critical role of p75 NTR during epileptogenesis.
To conclude, our results provide novel insights into the proBDNF/p75 NTR mechanisms and function in modulating chloride homeostasis during the development of neuronal networks and in the pathogenesis of epilepsy. Thus, our data suggest that under physiological conditions, proBDNF/p75 NTR to mBDNF/TrkB ratio may control the timing of the developmental shift of GABA depolarizing to hyperpolarizing in cortical and hippocampal neurons, and in pathophysiological response to SE, proBDNF via p75 NTR alters the excitatory/inhibitory equilibrium thereby enhancing neuronal activity through the inhibition of KCC2 function. Altogether, these data shed new light on the pivotal role of proBDNF/p75 NTR signaling in epileptogenesis and may explain some of the mechanisms that take place during this critical period. These results potentially lead to new therapeutic strategy to prevent the development of epilepsy. 
